Galunisertib monohydrate is a selective inhibitor of the TGF-β receptor type I (TGF-βRI), exhibiting an IC50 of 56 nM. This compound effectively modulates TGF-β signaling pathways, which are implicated in various fibrosis and cancer progression contexts. Galunisertib is utilized in research applications focusing on therapeutic strategies targeting TGF-βRI to mitigate tumor microenvironment effects and promote antitumor immunity.
Galunisertib monohydrate is a selective inhibitor of the TGF-β receptor type I (TGF-βRI), exhibiting an IC50 of 56 nM. This compound effectively modulates TGF-β signaling pathways, which are implicated in various fibrosis and cancer progression contexts. Galunisertib is utilized in research applications focusing on therapeutic strategies targeting TGF-βRI to mitigate tumor microenvironment effects and promote antitumor immunity.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
